Omecent 40 mg (Capsule (Enteric Coated))

Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)

Strip Price: ৳ 80.00

Medicine Details

Gastric and duodenal ulcer
NSAID-associated duodenal and gastric ulcer
Prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
Gastro-esophageal reflux disease
Long-term management of acid reflux disease
Acid-related dyspepsia
Severe ulcerating reflux esophagitis
Prophylaxis of acid aspiration during general anesthesia
Zollinger-Ellison syndrome
Helicobacter pylori-induced peptic ulcer

Direction for use of IV Injection
Direction for use of IV Infusion
Intravenous administration only
IV injection should be given slowly
IV infusion should be given over a period of 20-30 minutes or more
Reconstituted solution should not be mixed or co-administered with any other drug
Freshly prepared solution should be used within a specific timeframe

Decreased intragastric acidity affecting the absorption of other drugs
Metabolism through cytochrome P450 delaying the elimination of other drugs
Recommendation to monitor patients receiving warfarin or phenytoin
Plasma concentrations of Omeprazole and clarithromycin increased during concomitant administration
No evidence of interaction with specific drugs (phenacetin, theophylline, caffeine, etc.)
Simultaneous treatment with digoxin leads to a 10% increase in the bioavailability of digoxin

Contraindicated in patients with known hypersensitivity to omeprazole
Exclusion of malignancy in suspected cases of gastric ulcer before treatment initiation

Well tolerated with generally mild and reversible adverse reactions
Reported skin rash, urticaria, and pruritus
Photosensitivity, bullous eruption, and erythema multiforme reported in isolated cases
Diarrhea and headache reported
Gastrointestinal reactions like constipation, nausea/vomiting, flatulence, and abdominal pain
Dizziness, light-headedness, and feeling faint associated with treatment
Reversible mental confusion, agitation, depression, and hallucinations reported predominantly in severely ill patients
Arthritic and myalgic symptoms reported

No adverse effects on pregnancy or the health of the fetus/newborn child in prospective epidemiological studies
Omeprazole can be used during pregnancy
No information available on the passage of Omeprazole into breast milk or its effects on the neonate
Discontinuation of breastfeeding if the use of Omeprazole is considered essential
Safety and effectiveness not established in pediatric patients less than 18 years of age

Avoid concomitant use of clopidogrel and omeprazole
Observational studies suggest increased risk for osteoporosis-related fractures with PPI therapy
Atrophic gastritis noted occasionally in gastric corpus biopsies from long-term treated patients
Concomitant use with methotrexate may lead to methotrexate toxicities